Literature DB >> 15864125

Genetic factors related to unconjugated hyperbilirubinemia amongst adults.

Ching-Shan Huang1, May-Jen Huang, Min-Shung Lin, Sien-Sing Yang, Hsiu-Chen Teng, Kung-Sheng Tang.   

Abstract

Some variations in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene are involved in the development of unconjugated hyperbilirubinemia. We hypothesize that other genetic factors may also be associated with this disease. A total of 227 adults with normal routine haematology and liver function (apart from bilirubin testing for which they revealed bilirubin > or = 25.7 micromol/l and unconjugated bilirubin/total bilirubin > or = 80%), and 235 sex- and age-matched controls, were recruited. All subjects were analysed for UGT1A1, glucose-6-phosphate dehydrogenase (G6PD) and organic anion transporter polypeptide 2 (OATP2) genotypes using polymerase chain reaction-restriction fragment length polymorphism. The results indicated that G6PD deficiency, variant UGT1A1 gene and variant OATP2 gene were risk factors for hyperbilirubinemia. The odds ratios (OR) (with 95% confidence interval) were 220.83 (34.68-1406.30), 73.61 (17.01-318.63), 45.15 (11.19-182.22), 15.46 (4.35-54.99) and 6.51 (1.83-23.09), respectively, for individuals featuring the common UGT1A1/OATP2 haplotypes homozygous/heterozygous, compound heterozygous/heterozygous, compound heterozygous/wild-type, heterozygous/heterozygous and heterozygous/wild-type variations amongst subjects with normal G6PD activity. Amongst the subjects with G6PD deficiency, the OR was 159.00 (24.57-1028.94) for individuals carrying variations in both UGT1A1 and OATP2 genes. The UGT1A1/OATP2 haplotypes homozygous/wild-type, homozygous/compound heterozygous and homozygous/homozygous for G6PD normal and variant/wild-type for G6PD deficient individuals were only observed in the case group, and not in the control group. Amongst hyperbilirubinemic adults, bilirubin values tended to parallel variation status of their haplotypes. Adults featuring certain haplotypes in UGT1A1, OATP2 and G6PD genes face a high risk of developing unconjugated hyperbilirubinemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864125     DOI: 10.1097/01213011-200501000-00007

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  13 in total

1.  Genome-wide association of serum bilirubin levels in Korean population.

Authors:  Tae-Wook Kang; Hee-Jin Kim; Hyoungseok Ju; Jeong-Hwan Kim; Yeo-Jin Jeon; Han-Chul Lee; Ka-Kyung Kim; Jong-Won Kim; Siwoo Lee; Jong Yeol Kim; Seon-Young Kim; Yong Sung Kim
Journal:  Hum Mol Genet       Date:  2010-07-16       Impact factor: 6.150

2.  Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population.

Authors:  Marja K Pasanen; Janne T Backman; Pertti J Neuvonen; Mikko Niemi
Journal:  Eur J Clin Pharmacol       Date:  2006-04-21       Impact factor: 2.953

Review 3.  Pharmacogenomics of human OATP transporters.

Authors:  Jörg König; Annick Seithel; Ulrike Gradhand; Martin F Fromm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-09       Impact factor: 3.000

4.  Genome-wide association meta-analysis for total serum bilirubin levels.

Authors:  Andrew D Johnson; Maryam Kavousi; Albert V Smith; Ming-Huei Chen; Abbas Dehghan; Thor Aspelund; Jing-Ping Lin; Cornelia M van Duijn; Tamara B Harris; L Adrienne Cupples; Andre G Uitterlinden; Lenore Launer; Albert Hofman; Fernando Rivadeneira; Bruno Stricker; Qiong Yang; Christopher J O'Donnell; Vilmundur Gudnason; Jacqueline C Witteman
Journal:  Hum Mol Genet       Date:  2009-05-04       Impact factor: 6.150

5.  Effect of genetic variants of bilirubin metabolism on the degree of hyperbilirubinemia in African-American newborns.

Authors:  D L Schutzman; L M Baudhuin; E Gatien; S Ajayi; R J Wong
Journal:  J Perinatol       Date:  2016-12-15       Impact factor: 2.521

6.  Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.

Authors:  Suzette J Bielinski; High Seng Chai; Jyotishman Pathak; Jayant A Talwalkar; Paul J Limburg; Rachel E Gullerud; Hugues Sicotte; Eric W Klee; Jason L Ross; Jean-Pierre A Kocher; Iftikhar J Kullo; John A Heit; Gloria M Petersen; Mariza de Andrade; Christopher G Chute
Journal:  Mayo Clin Proc       Date:  2011-06-06       Impact factor: 7.616

Review 7.  Developmental, Genetic, Dietary, and Xenobiotic Influences on Neonatal Hyperbilirubinemia.

Authors:  Mei-Fei Yueh; Shujuan Chen; Nghia Nguyen; Robert H Tukey
Journal:  Mol Pharmacol       Date:  2017-03-10       Impact factor: 4.436

Review 8.  Impact of OATP transporters on pharmacokinetics.

Authors:  A Kalliokoski; M Niemi
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

9.  Multiple variants in UGT1A1 gene are factors to develop indirect hyper-bilirubinemia.

Authors:  Rei-Ting Hu; Nai-Yuan Wang; May-Jen Huang; Ching-Shan Huang; Ding-Shinn Chen; Sien-Sing Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2014-08       Impact factor: 7.293

10.  Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.

Authors:  Richard H Ho; Leena Choi; Wooin Lee; Gail Mayo; Ute I Schwarz; Rommel G Tirona; David G Bailey; C Michael Stein; Richard B Kim
Journal:  Pharmacogenet Genomics       Date:  2007-08       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.